Common Contracts
2 similar null contracts by Boston Scientific Corp
BOSTON SCIENTIFIC CORPORATION 8,750,000 Shares of 5.50% Mandatory Convertible Preferred Stock, Series A Underwriting AgreementBoston Scientific Corp • May 28th, 2020 • Surgical & medical instruments & apparatus • New York
Boston Scientific Corporation, a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 8,750,000 shares of 5.50% Mandatory Convertible Preferred Stock, Series A, with a liquidation preference of $100.00 per share (the “Mandatory Convertible Preferred Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 1,312,500 shares of Mandatory Convertible Preferred Stock (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”.
BOSTON SCIENTIFIC CORPORATION 25,550,000 Shares of Common Stock Underwriting AgreementBoston Scientific Corp • May 28th, 2020 • Surgical & medical instruments & apparatus • New York
Boston Scientific Corporation, a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 25,550,000 shares of common stock, $0.01 par value per share, of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 3,832,500 shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.
